Language
English
Publication Date
6-3-2025
Journal
Journal of the American College of Cardiology
DOI
10.1016/j.jacc.2025.03.518
PMID
40304643
Keywords
LDL-C-lowering therapy, PCSK9 inhibitors, adherence, treatment practice
Published Open-Access
yes
Recommended Citation
Christie M Ballantyne, Alberico L Catapano, and Khurram Nasir, "Oral PCSK9 Inhibitors: Can Novel Therapies Overcome Barriers to Effective LDL-Cholesterol Management?" (2025). Faculty, Staff and Students Publications. 6732.
https://digitalcommons.library.tmc.edu/baylor_docs/6732